HCID 58269385, compound → HCID 76750891, compound
Reaction equation
[NH2:1][C:2]1[N:11]=[CH:10][C:9]2[C:8](=O)[CH2:7][CH:6]([C:13]3[CH:18]=[CH:17][C:16]([F:19])=[CH:15][C:14]=3[C:20]3[CH:21]=[N:22][N:23]([CH3:25])[CH:24]=3)[CH2:5][C:4]=2[N:3]=1.NC1N=CC2C(=[N:37][OH:38])CC(C3C=CC(F)=CC=3C3C=NC=CC=3)CC=2N=1>>[NH2:1][C:2]1[N:11]=[CH:10][C:9]2[C:8](=[N:37][OH:38])[CH2:7][CH:6]([C:13]3[CH:18]=[CH:17][C:16]([F:19])=[CH:15][C:14]=3[C:20]3[CH:21]=[N:22][N:23]([CH3:25])[CH:24]=3)[CH2:5][C:4]=2[N:3]=1Participants
3
Procedure
The title compound was prepared from 2-amino-7-[4-fluoro-2-(1-methyl-1H-pyrazol-4-yl)-phenyl]-7,8-dihydro-6H-quinazolin-5-one from stage 1, following the procedure describing the synthesis of 2-amino-7-(4-fluoro-2-pyridin-3-yl-phenyl)-7,8-dihydro-6H-quinazolin-5-one oxime (example 4/a stage 2).
Sources & evidence
- ORD record
- ord-5e6c152aab4649c0bbbedfa9dc7467ed
- Source dataset
- uspto-grants-2013_11
- Patent number
- US08592430B2
Reaction notes
Loading…